Gowtham Grandhi (@gowthyharsha) 's Twitter Profile
Gowtham Grandhi

@gowthyharsha

@VCUHealthHeart cardiology fellow | @hopkinsheart CV prevention/cardiometabolic fellow | Interest : CV prevention and imaging

ID: 220898271

calendar_today29-11-2010 04:33:56

419 Tweet

470 Followers

1,1K Following

Penn Cardiology (@penncardiology) 's Twitter Profile Photo

Due to the growing risks of #cardiometabolicdisease, public health & policy strategies are needed to 📈 access to: 👉effective pharmacotherapies 👉low cost healthy food 👉timely care Learn more in an article by Penn Heart & Vascular's #DanielSofferMD et al. spr.ly/60113INtX

Due to the growing risks of #cardiometabolicdisease, public health & policy strategies are needed to 📈 access to:

👉effective pharmacotherapies
👉low cost healthy food 
👉timely care

Learn more in an article by <a href="/PennCardiology/">Penn Heart & Vascular</a>'s #DanielSofferMD et al.

spr.ly/60113INtX
Anurag Mehta (@amehta_09) 's Twitter Profile Photo

Does Elevated High-Density Lipoprotein #HDL Cholesterol Protect Against Cardiovascular Disease? #cvprev Led by 🌟FIT Alexander C. Razavi academic.oup.com/jcem/advance-a…

Anum Saeed (@anumsaeedmd) 's Twitter Profile Photo

Status of #cvPrev training in the 🇺🇸—- not much 🤷🏻‍♀️ Excellent perspective and thought provoking questions by Dr. Maron….we have work to do! ASPC #ASPC2023

Status of #cvPrev training in the 🇺🇸—- not much 🤷🏻‍♀️ 

Excellent perspective and thought provoking questions by Dr. Maron….we have work to do! <a href="/ASPCardio/">ASPC</a> #ASPC2023
Claire Cambron (@clairecambron) 's Twitter Profile Photo

CAC-PREVENTABLE is an exciting ancillary trial exploring the utility of coronary artery calcification (CAC) as a predictor for benefit of statin 💊 therapy in PREVENTABLE. 👏 Great talk by Dr. Melissa Daubert 👏

CAC-PREVENTABLE is an exciting ancillary trial exploring the utility of coronary artery calcification (CAC) as a predictor for benefit of statin 💊 therapy in PREVENTABLE.

👏 Great talk by Dr. Melissa Daubert 👏
Ellen Boakye, MD MPH (@ellen_a_boakye) 's Twitter Profile Photo

🚨 📌CVD risk-stratification among persons w/ obesity is key esp in this era of expanded obesity pharmacotherapy 📌CAC may help identify optimal candidates for novel but costly anti-obesity medications Michael J. Blaha Michael Albert, MD Roger Blumenthal Khurram Nasir onlinelibrary.wiley.com/doi/10.1002/ob…

Priyanka Satish (@psatishmd) 's Twitter Profile Photo

Celebrating #Diwali at #AHA23 with great friends and good Indian food #vegthali #masaladosa Thanks Shanjeev Kumar for the restaurant suggestion! We missed you guys @AAgarwalaMD Anum Saeed Jaideep

Celebrating #Diwali at #AHA23 with great friends and good Indian food #vegthali #masaladosa 

Thanks <a href="/Shanjeev96/">Shanjeev Kumar</a> for the restaurant suggestion! 

We missed you guys @AAgarwalaMD <a href="/AnumSaeedMD/">Anum Saeed</a>  <a href="/jaideeppatelmd/">Jaideep</a>
Roger Blumenthal (@rblument1) 's Twitter Profile Photo

PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): prospective study protocol investigating prevalence, severity & determinants of atherosclerotic CVD in the young adult Pakistani pop… BMJ_Open bmjopen.bmj.com/content/13/11/…

Rodrigo Alonso Karlezi (@karlezialonso) 's Twitter Profile Photo

FH pts, no clinical CAD, mean age 48 y; treated median 11 years, LDL-C 155 mg/dL. 42% CAC=0 & 33% no plaque in CTA, varying by age and sex. We Should use more imaging in FH to improve risk stratification Fundación HF Red Iberoamericana de Hipercolesterolemia Familiar European Atherosclerosis Society doi.org/10.1016/j.ajpc…

FH pts, no clinical CAD, mean age 48 y; treated median 11 years, LDL-C 155 mg/dL. 42% CAC=0 &amp; 33% no plaque in CTA, varying by age and sex. We Should use more imaging in FH to improve risk stratification 
<a href="/FHFamiliar/">Fundación HF</a> <a href="/HFIberoamerica/">Red Iberoamericana de Hipercolesterolemia Familiar</a> <a href="/society_eas/">European Atherosclerosis Society</a> 
doi.org/10.1016/j.ajpc…
Michael J. Blaha (@michaeljblaha) 's Twitter Profile Photo

It is time again to recruit for our Cardiometabolic Fellowship in the Johns Hopkins Ciccarone Center. This is dedicated for those with SPECIFIC interest in preventive cardiology and cardiometabolic disease. If interested, please DM me and I will ask for your CV and PS.

JACC Journals (@jaccjournals) 's Twitter Profile Photo

We're pleased to announce Dr. Harlan M. Krumholz, a globally esteemed cardiologist and researcher, as the incoming editor-in-chief of #JACC! Join us in celebrating his appointment and learn more about his incredible contributions to the field: bit.ly/3Te9XfF Harlan Krumholz

We're pleased to announce Dr. Harlan M. Krumholz, a globally esteemed cardiologist and researcher, as the incoming editor-in-chief of #JACC!

Join us in celebrating his appointment and learn more about his incredible contributions to the field: bit.ly/3Te9XfF <a href="/hmkyale/">Harlan Krumholz</a>
Jaideep (@jaideeppatelmd) 's Twitter Profile Photo

Challenges in the Cardiovascular Evaluation and Management of Patients With Obesity ⁦Sean Gaine⁩ ⭐️ #cvPrev ⁦Roger BlumenthalGowtham Grandhi⁩ ⁦Michael J. Blaha⁩ ⁦@AAgarwalaMD⁩ ⁦Eugenia Gianos MD⁩ ⁦Eugene Yang⁩ acc.org/latest-in-card…

Jaideep (@jaideeppatelmd) 's Twitter Profile Photo

Excited to share our inaugural paper from the DILWALE South Asian CV Health Registry established by Anandita Agarwala Kulkarni, MD FACC 🔗sciencedirect.com/science/articl… -31K adults (largest 🇺🇸 cohort) -⬆️ RF burden: HTN,DM -RFs highest in 🚹 & premature CVD -HTN & HLD a/w 3.5x CVD risk -🚺under Rx w LLT

Excited to share our inaugural paper from the DILWALE South Asian CV Health Registry established by <a href="/AAgarwalaMD/">Anandita Agarwala Kulkarni, MD FACC</a> 

🔗sciencedirect.com/science/articl…
 
-31K adults (largest 🇺🇸 cohort)
-⬆️ RF burden: HTN,DM
-RFs highest in 🚹 &amp; premature CVD
-HTN &amp; HLD a/w 3.5x CVD risk
-🚺under Rx w LLT